Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway
Molecular Nutrition & Food Research · 2024-02 · 68 (4)
DOI: 10.1002/mnfr.202200771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 14.02.2024. Verfasst von Chang Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, School of Medicine, Nankai University Tianjin, Tianjin, 300071, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Experimental, Furans, Lignans. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Natural Science Foundation, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Scope Early diabetic retinopathy (DR) is characterized by chronic inflammation, excessive oxidative stress, and retinal microvascular damage. Syringaresinol (SYR), as a natural polyphenolic compound, has been proved to inhibit many disease progression due to its antiinflammatory and antioxidant properties. The present study focuses on exploring the effect of SYR on hyperglycemia‐induced early DR as well as the underlying mechanisms. Methods and results Wild‐type (WT) and nuclear factor erythroid 2‐related factor 2 (Nrf2)‐knockout C57BL/6 mice of type 1 diabetes and high glucose (HG)‐induced RF/6A cells are used as in vivo and in vitro models, respectively. This study finds that SYR protects the retinal structure and function in diabetic mice and reduces the permeability and apoptosis of HG‐treated RF/6A cells. Meanwhile, SYR distinctly mitigates inflammation and oxidative stress in vivo and vitro. The retinal microvascular damages are suppressed by SYR via downregulating hypoxia‐inducible factor‐1α (HIF‐1α)/vascular endothelial growth factor (VEGF) pathway. Whereas, SYR‐provided protective effects are diminished in Nrf2‐knockout mice, indicating that SYR improves DR progression by activating Nrf2. Similarly, SYR cannot exert protective effects against HG‐induced oxidative stress and endothelial injury in small interfering RNA (siRNA)‐Nrf2‐transfected RF/6A cells. Conclusion In summary, SYR suppresses oxidative stress via activating Nrf2 antioxidant pathway, which ameliorates retinal microvascular damage by downregulating HIF‐1α/VEGF, thereby alleviating early DR progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, School of Medicine, Nankai University Tianjin, Tianjin, 300071, China.
- Nankai University Eye Institute, Tianjin, 300071, China.
- Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Clinical College of Ophthalmology Tianjin Medical University, Tianjin, 300020,…
- Department of General Surgery, Tianjin Union Medical Center, Tianjin, 300122, China.
- Tianjin Union Medical Center, Tianjin, 300122, China.
- Xinjiang Production and Construction Corps Hospital, Xinjiang, 830002, China.
ORCID-Profile: Chang Liu
Förderung
- National Natural Science Foundation of China
- Tianjin Natural Science Foundation
- Fundamental Research Funds for the Central Universities
- Nankai University Eye Institute
- Tianjin Key Medical Discipline (Specialty) Construction Project
- Tianjin Health Research Project
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Liu, C., Cheng, T., Wang, Y., Li, G., Wang, Y., Tian, W., Feng, L., Zhang, S., Xu, Y., Gao, Y., Li, J., Liu, J., Cui, J., Yan, J., Cao, L., Pan, Z., Qi, Z., & Yang, L. (2024). Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway. Molecular Nutrition & Food Research, 68(4). https://doi.org/10.1002/mnfr.202200771
Vancouver
Liu C, Cheng T, Wang Y, Li G, Wang Y, Tian W, et al. Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway. Molecular Nutrition & Food Research. 2024;68(4). doi:10.1002/mnfr.202200771
BibTeX
@article{Liu2024,
author = {Liu, Chang and Cheng, Tianwei and Wang, Yufei and Li, Guangru and Wang, Yachen and Tian, Wencong and Feng, Lifeng and Zhang, Shengzheng and Xu, Yang and Gao, Yang and Li, Jing and Liu, Jie and Cui, Jianlin and Yan, Jie and Cao, Lei and Pan, Zhongjie and Qi, Zhi and Yang, Liang},
title = {Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway},
journal = {Molecular Nutrition & Food Research},
year = {2024},
volume = {68},
number = {4},
doi = {10.1002/mnfr.202200771}
}
EUVIMED